Clinical trial
Combination Therapy Selection Trial in Amyotrophic Lateral Sclerosis
NCT00355576 · Columbia University, Other · Completed
Key facts
| NCT number | NCT00355576 |
|---|---|
| Title | Combination Therapy Selection Trial in Amyotrophic Lateral Sclerosis |
| Official title | Phase II Combination Therapy Selection Trial in Amyotrophic Lateral Sclerosis |
| Lead sponsor | Columbia University, Other |
| Collaborators | ALS Association Pfizer Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Amyotrophic Lateral Sclerosis |
| Intervention type | Drug |
| Interventions | Celecoxib, Creatine, Minocycline |
| Enrollment | 86 |
| Start date | Jul 1, 2006 |
| Completion | May 1, 2007 |
| First posted | Jul 24, 2006 |
| Last update posted | Feb 1, 2011 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: